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Promiscuous Antigen Presentation by the Nonclassical
MHC Ib Qa-2 Is Enabled by a Shallow, Hydrophobic
Groove and Self-Stabilized Peptide Conformation
[1]. These MHC antigens associate with short, 8–10
amino acid peptides that have been processed from
larger proteins through specific degradative pathways
[2]. The best characterized members of this family, the
classical (class Ia) MHC antigens H-2K, H-2D, and H-2L
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2 Center for Immunology ing intracellular pathogen infections. The peptide-MHC
complexes present a composite recognition surface toDepartment of Microbiology and
Department of Internal Medicine the polymorphic CDR loops of T cell receptors, which,
when engaged, target the infected cell for lysis [1]. SomeUniversity of Texas
Southwestern Medical Center class Ia MHC also serve as ligands in the innate immune
system for inhibitory/activating natural killer (NK) Ly49,Dallas, Texas 75390
KIR, and CD94/NKG2 receptors [3]. The detailed struc-
tures of many of these class Ia proteins have been re-
ported [4, 5], and much has been learned about their
interactions with peptides,-2 microglobulin (2M), CD8,Summary
and cognate T cell and NK receptors [6–8].
Structural and functional investigations of the non-Background: Qa-2 is a nonclassical MHC Ib antigen,
which has been implicated in both innate and adaptive classical (class Ib) family of MHC have lagged behind
the class Ia studies [9–12]. Recently, however, researchimmune responses, as well as embryonic development.
Qa-2 has an unusual peptide binding specificity in that in this area has intensified as it became clear that many
of the non-polymorphic class Ib proteins perform spe-it requires two dominant C-terminal anchor residues and
is capable of associating with a substantially more di- cialized functions in the immune and nonimmune sys-
tems and exert important immunoregulatory effects [12].verse array of peptide sequences than other nonclassi-
cal MHC. Interestingly, each of the class Ib studied so far have
exhibited a wider spectrum of diversity in structural and
recognition properties than has been observed for mem-Results: We have determined the crystal structure, to
2.3 A˚, of the Q9 gene of murine Qa-2 complexed with a bers of the classical MHC family [11]. Although the
known class Ia and class Ib exhibit structural similaritiesself-peptide derived from the L19 ribosomal protein,
which is abundant in the pool of peptides eluted from (MHC-like fold; 1, 2, and 3 domains; association with
2M, etc.), they have evolved diverse binding groovesthe Q9 groove. The 9 amino acid peptide is bound high
in a shallow, hydrophobic binding groove of Q9, which to carry out their specialized functions.
Q9 antigen, one of the best-characterized murineis missing a C pocket. The peptide makes few specific
contacts and exhibits extremely poor shape comple- class Ib proteins, is a member of the Qa-2 family of
nonpolymorphic MHC proteins encoded in the Q regionmentarity to the MHC groove, which facilitates the pre-
sentation of a degenerate array of sequences. The L19 of H-2 [13]. It is widely expressed on TAP-positive cells/
tissues and has been detected in many class Ia-low,peptide is in a centrally bulged conformation that is
stabilized by intramolecular interactions from the invari- immunologically privileged sites, including the anterior
chamber of the eye, hair follicle, embryo/placenta, andant P7 histidine anchor residue and by a hydrophobic
core of preferred secondary anchor residues that have testis, respectively [14–17]. Q9 shares extensive homol-
ogy with H-2K, H-2D, and H-2L alleles (82%, 84%, andminimal interaction with the MHC.
82% aminoacid identity with H-2Kb, H-2Db, and H-2Ld,
respectively) and is more similar, at the protein se-Conclusions: Unexpectedly, the preferred secondary
peptide residues that exhibit tenuous contact with Q9 quence level, to class Ia than to any other non-Q class
Ib protein.contribute significantly to the overall stability of the pep-
tide-MHC complex. The structure of this complex im- Q9 is an unusual MHC class I protein in several re-
spects. It is attached to cell surfaces via a glycosylphos-plies a “conformational” selection by Q9 for peptide
residues that optimally stabilize the large bulge rather phatidylinositol (GPI) anchor rather than a hydrophobic
transmembrane segment, similar to NKG2D, used by allthan making intimate contact with the MHC pockets.
other class I MHC [18]. The GPI moiety is responsible
for the clustering of Q9 in lipid rafts [19], transductionIntroduction
of activation signals upon crosslinkng of Q9 on T cells
[20], and preferential expression on apical surfaces ofMembers of the class I-like Major Histocompatibility
Complex (MHC) family of antigens participate in a wide polarized epithelial cells [21]. Q9 proteins are expressed
also as soluble proteins arising by alternative splicingrange of distinct innate and adaptive immune responses
3 Correspondence: kcgarcia@stanford.edu Key words: MHC; nonclassical; X-ray crystallography; immune rec-
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Structure
1214
Table 1. Sequences of Qa-2 Binding Peptides
Position of Residue
Pool P1 P2 P3 P4 P5 P6 P7 P8 P9 Comments
Dominant residues H L
I
F
Strong K M N P V K E
L I I M Q
Q L I N Residues detected
D in the pool of
endogenous peptides
eluted from Qa-2a
Also detected A T E L L R K
E A T F S
Q G E N T
(G) K H Y R
S M (V)
D F
Y
(Q)
Individual Peptides
L19 I L M E H I H K L Endogenous
COF K L T G I K H E L peptidesb
RVG (pep2) N Q L V N L H D L Pathogen-derived
RVN (pep3) R Q I V E H H T L peptidesc
Rota V (pep 10) L M N D T L H S I
Ade (pep 13) G L L E A E H P F
a Data are derived from [27]. Letters correspond to residues of peptides eluted from membrane bound Q9. Additional residues detected in
the peptide pool eluted from soluble Q9 are indicated in parentheses [28]. Proposed anchors are in bold. Positions with restricted occupancy
are underlined.
b Sequences of endogenous peptides are from [28]; peptide binding was tested in [29]. Abbreviations: L19, ribosomal L19; COF, cofilin.
c Sequences of synthetic peptides corresponding to pathogen-derived and alanine backbone peptides. Peptide binding was tested in [29].
Abbreviations: RVG, rabies virus glycoprotein; RVN, rabies virus nucleoprotein; RotaV, rotavirus VPG protein receptor; Ade, adenovirus type
40 DNA stabilization protein E1B19K.
and posttranslational cleavage of membrane forms [22]. sensitive histidine residue as one of the two dominant
anchors. The position of this anchor, at P7, close toAlthough the physiological functions of Q9 products are
currently poorly defined, the evidence suggests that Q9 the ubiquitous P9 hydrophobic anchor, is also highly
unusual since other peptides bind to the known class Iplays a role in a variety of immune responses. The GPI
bound Q9 serves as a target for alloreactive CD8 CTL, MHC grooves via a more N-terminally localized P2-, P3-,
or P5-dominant anchor. The sequencing of endogenousinfluences maintenance/selection of a subpopulation of
CD8 iIEL, and blocks cytolytic activity of NK (LAK) cells peptide pools and individual peptides from GPI-linked
[27] and soluble [28] Qa-2 also revealed that they prefer-[23, 24]. These effects and Q9’s structural similarities to
class Ia MHC proteins imply that Q9 engages T cell entially use selected amino acids at other positions,
particularly at P2 and P3 (Table 1). Consistent with thesereceptors of CTL, iIEL, and inhibitory receptors of NK/
NKT cells. Whether Q9 is a ligand for TCR or NK recep- observations, nonameric synthetic peptides containing
different permutations of predicted dominant and auxil-tors, or both, is a question being actively pursued. Inter-
estingly, Q9 has also been shown to be the gene product iary anchors bind Q9 with high affinity (Table 1). Overall,
Q9 binding peptides resemble class Ia ligands in termsof the preimplantation development (PED) locus in mice,
which controls the rate of cleavage division of preim- of their length, diversity, and number of dominant (two)
and auxiliary (one to two) anchors needed for efficientplantation mouse embryos and subsequent embryonic
survival [26]. Hence, Q9 may have a function and a ligand tethering into the groove. Individual peptides display,
however “alternative” binding motifs, suggesting thatseparate from those involved in immune responses.
Q9 can bind a wide array of both self- and pathogen- different ligands utilize distinct features/residues to sta-
bilize Q9 complexes.derived 8–9 amino acid-long peptides (summarized in
Table 1). This feature sets it apart from most class Ib In this paper we report the crystal structure of the
Qa-2 antigen derived from the Q9 allele complexed withproteins, which are highly restricted in their antigen pre-
sentation functions. The peptide binding motif of Qa-2 2M and the endogenous nonamer peptide (ILMEHIHKL)
derived from a cytosolic self-protein, ribosomal L19,was defined by the sequencing of endogenous peptides
eluted from Qa-2 molecules [27, 28] and by in vitro stud- which is abundant in the groove of Q9 purified from B
cells. The complex shares overall similarity with classies of synthetic peptide binding to Q9 [29]. The motif is
unique in that it uses almost exclusively a rare, pH- Ia structures but has a shallower hydrophobic groove
Crystal Structure of a Nonclassical MHC-Peptide Complex
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Figure 1. Three-Dimensional Structure of Q9 Complexed to the L19 Peptide
(a) Ribbon model of Q9 complexed to L19 peptide as one looks down the groove axis.
(b,c) Superposition of Q9 with H-2Kb as viewed for the overall structure and over the peptide binding groove, respectively. (Figures throughout
this paper produced with MOLSCRIPT [52] and rendered with Raster3d [53]).
that may be responsible for binding of a wide repertoire The Unique Conformation of the Bound Peptide
Q9 was cocrystallized with an endogenous self-peptideof peptides with relatively little sequence specificity. The
derived from the L19 ribosomal protein [28]. The peptidesequence biases observed in Qa-2-associated peptides
contains the two dominant anchor residues, P7-His andmay be partially imposed by the bound ligands, whose
P9-Leu (or hydrophobic residues), as well as hydropho-intramolecular interactions constrain the peptide into a
bic residues at P2, P3, P5, and P6, which are favored bybulged conformation.
Q9 as determined from peptide pool sequencing studies
(Table 1) [28]. In Table 1, we show the set of Qa-2 binding
Results and Discussion peptides isolated from pooled sequencing studies. The
L19 sequence came from sequencing an individual
Overall Structure eluted peptide. L19 is one of the most abundant pep-
As expected from the high degree of sequence homol- tides in the Qa-2 mixture, yet it is one of possibly thou-
ogy (82%–85%), the overall quaternary and tertiary sands of peptides binding to Qa-2 (see bottom rows of
structures of Q9 are similar to the previously reported Table 1). The L19 peptide encapsulates the chemical
classical MHC I structures (Figure 1 and Table 2). The features of many Qa-2 binding peptides and so can
 chain folds into three domains (1, 2, and 3) and is serve as a representative structure for extrapolations to
associated with 2M. The 1 and 2 domains form a the canonical set of Qa-2 binding peptides.
binding groove with two long, antiparallel -helical The electron density of the L19 peptide enabled a clear
structures sitting atop the  sheet platform. The width tracing of the 9 residue synthetic peptide (Figures 2a and
of the groove between the 1 and 2 helices is “stan- 2b) (NH2-Ile-Leu-Met-Glu-His-Ile-His-Lys-Leu-COOH).
dard” for a classical peptide binding MHC groove, and The L19 peptide is bound in the groove of Q9 with its
this groove does not show gross deviations from those N and C termini fixed within the terminal A and F pockets,
of classical MHC, as does, for instance, CD1d, which respectively, which is highly reminiscent of peptides
has a narrow, occluded groove, or M3, whose groove bound to class Ia MHC (Figures 2 and 3a) [30]. However,
is closed at the N-terminal end. The root mean square the central peptide residues are not extended but form
deviation (rmsd) between Q9 and the crystal structures a compact bulge that arches substantially out of the
of H-2Kb and H-2Db for all C atoms in the heavy chain groove (Figures 2b and 2c). The conformation of the
is 1.57 A˚ and 1.72 A˚, respectively (Figures 1b and 1c). bulge appears to be stabilized, in part, by intramolecular
This similarity is roughly equal to that of values found interactions (Figure 2c). P7-His, the dominant anchor
residue, is H bonded to the main-chain CO of P5, andbetween individual members of the class Ia family.
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Table 2. Crystallographic Statistics
Data Collection
Resolution (A˚) (outer-most resolution shell) 60–2.3 (2.38–2.30)
Measured reflections 61,755
Unique reflections 16,467
Completeness (%) 97.6 (99.0)
Rmergea (%) 11.2 (37.0)
Refinement Statistics
Resolution range (A˚) 60.0–2.3 (2.38–2.30)
Rcrystb 0.223 (0.285)
Rfreec 0.278 (0.365)
Number of protein atoms 3070
Number of waters 329
Average B-factors (A˚2)
Protein 29.5
Peptide 31.6
Solvent 37.7
Rms deviation from ideality
Bond lengths (A˚) 0.007
Bond angles () 1.4
Dihedrals () 24.6
Impropers () 0.8
B factors (A˚2) 2.4
Ramachandran plot (%)
Most favored 88.7
Not allowed 0
a Rmerge  hkl|I  I	|/hklI, where I is the intensity of unique reflection hkl, and I	 is the average over symmetry-related observation of
unique reflection hkl.
b Rcryst  |Fobs  Fcalc/Fobs, where Fobs and Fcalc are the observed and the calculated structure factors, respectively.
c Rfree is R calculated by using 5% of reflections sequested before refinement.
a hydrophobic stacking interaction occurs between the sequence in a solvent-exposed portion of the peptide,
as has been seen for the “kink” in numerous class IaP3-Met side chain (C and C
) and the hydrophobic
methylene atoms of the P5-His sidechain (C and C
) bound peptides [34]. In other class I MHC, the solvent-
exposed kinks are not self stabilized and exhibit flexibil-(Figure 2c). In total, the bulge involves P3–P7. On this
bulge, P3 is partially exposed, and P4, P5, and P6 all ity that is consistent with a simple looping-out accom-
modation of sequence. Although the L19 bulge traversespoint their side chains toward the outside of the groove
(Figure 3a). P8-Lys at the C-terminal end of the peptide a shallow region of the groove, the bulge is only mini-
mally supported underneath by the floor of the MHCis also extended outward toward solvent, but this is not
due to the central arch. Rather, P8 is forced upward by groove (Figure 4a). In most class Ia MHC, the entire
length of the peptides are extended, with the kink mak-a bulky Trp residue on Q9 underneath the peptide. This
residue obstructs the path between P7 in the E pocket ing intimate contact with an arch in the MHC groove
(Figures 2b–2e; [32]). A third distinguishing feature isand P9 in the F pocket. The side chains of five of the
nine total L19 side chains are solvent-accessible from that the Q9 peptide is higher up in the groove than other
MHC (Figures 3a and 4a) (discussed below).the outside of the groove.
Compared with other MHC I bound peptides (Figure Despite the fact the Qa-2 binding peptides exhibit
strong secondary preferences at P2, P3, P4, and P5,2d), the peptide conformation of Q9 is unique in three
respects. First, the position of the bulge encompasses these positions have only minimal contact with the MHC
in the structure (Figures 3 and 4a), yet they contributethe central five (P2–P7) amino acids of the peptide (Fig-
ures 2b and 2c), whereas the classical murine MHC I, significantly to the overall stability of the peptide-Q9
complex. The intramolecular interactions stabilizing thesuch as H-2Kb, H-2Db, and H-2Ld, have kinks mainly
located at the C-terminal part of the peptide (Figure 2d) bulge are utilizing the conserved features of the peptide
such as the invariant P7-His and the preferred auxiliarybecause of steric impositions by the MHC that force the
peptide out [31–33]. Human class I, however, bulge at residues at P3 and P5 (Figure 2c; Table 1). Therefore,
the secondary preferences appear to result from selec-the P4–P5 positions, which, like in Qa-2, are more cen-
tral. Second, the Q9 peptide bulge appears to be self tion for stabilization of the “core” of the bulge, and the
intramolecularly stabilized conformation should be astabilized by the intramolecular interactions that rigidify
the solvent-exposed loop (Figures 2c and 3a). The ther- common feature of Qa-2 peptides. Interestingly, by com-
parison we found the only peptide resembling the Q9mal factors (i.e., B factors, indicators of thermal motion)
are normal, and the electron density of the bulged resi- peptide C trace is that bound in HLA-E (Figure 2d;
[35]), another nonclassical MHC I. However, the HLA-Edues is excellent, indicating a unique and rigid confor-
mation (Figures 2a and 2b). This bulge is not simply a peptide is deeply bound in the MHC groove, with all the
possible binding capacity utilized (Figure 4d). Impor-means of absorbing extra length by looping out excess
Crystal Structure of a Nonclassical MHC-Peptide Complex
1217
Figure 2. Conformation of the L19 Peptide When Bound to Q9
(a) Electron density (omit 2Fo  Fc) of the L19 peptide sitting in the Q9 groove, as viewed from the top.
(b) SIGMAA-weighted 2Fo  Fc omit electron density at 2.3 A˚ of the L19 peptide as viewed from the side of the groove. Peptide residues are
labeled, and atoms of the peptide are present within the electron density cage.
(c) Conformation of the intramolecularly stabilized bulge in the L19 peptide. The hydrogen bond between His7 and the P5 CO is drawn as a
dotted line, and van der Waals interactions involving preferred secondary residues are shown as dashed lines.
tantly, the bulge in HLA-E is not due to intramolecular backbone of the L19 peptide, as is seen on most MHC-
peptide complexes, provide a sequence-independentstabilization but is due to bulky aromatics in the MHC
groove that force the peptide upward, as for Db. binding stabilization (Figure 3b; [7]). The L19 peptide
forms a total of 12 hydrogen bonds with Q9 residues,
whereas the Flu Np peptide forms 22 H bonds (13 usingHydrogen Bonding Interactions between the L19
peptide main-chain atoms, nine using side-chain atoms)Peptide and Q9
with Db cleft residues, and SEV peptide forms 21 H bondsThe L19 peptide associates with Q9 primarily through
(18 main chain, three side chain) with H-2Kb residues.a shallow and hydrophobic peptide binding groove that
Clearly, there is a significant reduction in the specificappears to place limits on the peptide specificity of Q9.
binding contacts between peptide and Q9, which is con-Out of the total 12 hydrogen bonds between the peptide
sistent with the observation of Qa-2 as a promiscuousand Q9, eight are both main chain and independent of
binder [28].sequence, and only two involve the side-chain atoms
of peptide residues (Figure 3b). Of the two side-chain-
specific H bonds, only one is between an anchor residue, Q9 Pocket Interactions
The MHC peptide binding “pockets” of Q9 (Figure 3) dothe invariant P7, and an MHC pocket, which should be
a conserved feature of Qa-2 peptides. The main-chain not make intimate contact with the side chains of the
peptide (Figure 4a). These pockets, canonically definedH bonds between the MHC helices and the peptide
Structure
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Figure 3. Intermolecular Interactions between
the L19 Peptide and Q9
(a) All-atom representation of the L19 peptide
(cyan) and amino acid residues with which it
interacts in the Q9 groove. The identity of Q9
residues is indicated, and the A, B, D, E, and
F pocket residues of Q9 are colored pink,
orange, red, blue, and green, respectively.
(b) Two-dimensional planar representation of
the interactions between L19 and Q9 in an
orientation roughly corresponding to that shown
in (a). The peptide is colored cyan, with oxy-
gen atoms red and nitrogen atoms blue.
from class Ia structures [30, 36], are present in Q9 but Ala6, and Val34, which form a deep hydrophobic base
of the pocket. In contrast to the A pocket, the Q9 Bdiffer in a number of significant ways. The A pocket
forms the conserved hydrogen bonds (Tyr7 OH-P1 N; pocket is deeper than that in H-2Kb. The Glu24Ser, Tyr4-
5Met, and Tyr22Phe differences increase the capacityTyr171 OH-P1 N), seen in essentially all MHC I, for stabi-
lizing the charged N terminus of the peptide (Figure 3). from the bottom, but the Ala9His and Asn70His muta-
tions decrease the capacity from the side wall and nar-However, the residues Tyr7 and Tyr171 at the base of
the A pocket are higher up than in H-2Kb, which reduces row the B pocket. This pocket is adjacent to the high
ridge composed of His70, Tyr99, Trp97, and Tyr159.the depth of this pocket. The most interesting feature
of the Q9 A pocket is the lack of the bulky position 167 Thus, although the B pocket is deep, its volume cannot
be fully occupied due to steric clashes with the ridge.side chain seen in other MHC Ia such as H-2Kb, H-2Db,
and HLA-E, where there is a conserved Trp167. In Q9, The C pocket, which is very important in H-2Kb for
accommodating the central aromatic anchor residue, isthe Trp167Ser substitution widens the A pocket, and
this reduction in steric bulk renders the Q9 groove dis- not present in Q9. In the position corresponding to the
canonical MHC Ia C pocket, Q9 uses large amino acidtinct from class Ia MHC in that one end is not closed
(Figure 4, right panels). The B pocket and D pockets side chains to fill the C pocket. For instance, Q9 substitutes
Val9His and Ser99Tyr, as compared to the C pocket resi-point laterally to the side wall of the groove. The P2
residue interacts with the B pocket consisting of Met45, dues in H-2Kb, to occupy the space from the bottom
Crystal Structure of a Nonclassical MHC-Peptide Complex
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Figure 4. Shape Complementarity and Hydrophobicity of Peptide Interactions of Q9 Compared to Other Classical and Nonclassical MHC-
Peptide Complexes
The left column of panels shows cross-sections (side view) of molecular surfaces of Q9-L19 and various classical and nonclassical peptide-
MHC complexes. The Q9-L19 shape complementarity is significantly poorer than the rest, as evidenced by the large spaces between the
peptide surface (red) and the floor of the Q9 groove (blue). Also, the L19 peptide sits significantly higher up in the groove than the others
because of the shallower groove floor. The right panel of columns shows the electrostatic surfaces of the empty grooves of the same peptide-
MHC complexes after the peptide residues have been removed. Pocket positions of Q9 are labeled in yellow. The Q9 groove is significantly
shallower and less polar than the others. In this representation, blue is basic, red is acidic, and white is nonpolar or hydrophobic. From the
top panel, the molecules shown are Qa-2/L19, H-2Db-K3G [32], H-2Kb-VSV8 [46], HLA-E-leader peptide [35].
and uses Val97Trp and Asn70His to occupy the space The D pocket is shallow and hydrophobic, which per-
fectly accommodates the P3 amino acid preference forfrom the opposite sides, which completely closes the
C pocket. Met or other hydrophobics. The Trp97-Tyr99 ridge is
Structure
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directly below the P3 residue and forms one side and example, His9, unique in Q9, is located at the bottom
of the B pocket and also contributes to the closure ofthe bottom of the pocket. On the other side, Tyr159,
Leu114, and Asp156 barely separate the D pocket from the C pocket. The enhanced hydrophobicity of the Q9
peptide binding groove, in comparison to that of classthe E pocket. In actuality, the D and E pockets are almost
continuous, which allows the P3 and P7 side chains to Ia MHC, is contributed largely by the two aromatic ridges
on the bottom and numerous hydrophobic substitutions.form a van der Waals interaction that stabilizes the bulge
in the peptide.
Composed of residues Trp133, Leu124, Leu114, Structural Features Explaining Why Q9 Binds
Phe116, Trp147, the E pocket is also shallow and hy- a Wide Repertoire of Peptides
drophobic (Figure 4a). The exception is the acidic Q9 peptides possess two dominant anchor residues,
Asp156 on one side. The P7 histidine residue uses its both located at the C terminus (P7 and P9) (Table 1).
N
 atom to form a salt bridge with the OD2 atom of the There are no major anchor residues at the N terminus.
Asp156 (2.54 A˚) and uses the hydrophobic portion of Of the two major anchors, only P7 forms a side-chain-
the ring to make van der Waals interactions with the specific H bond with Q9; P9 inserts into a hydrophobic
shallow base of the pocket. In principle, an arginine, pocket. The few sequence-specific structural interac-
which occurs rarely at this position in Q9 peptides but tions we see between the peptide and cleft dramatically
is capable of functioning as a P7 anchor, could also decrease the peptide specificity of this complex (Figure
satisfy these chemical and structural criteria. The spe- 3b). In fact, although the peptide does not exhibit highly
cific organization of the E pocket makes the only side- selective structural interactions with Q9 in the cleft, it
chain-specific hydrogen bond with the P7 position, is self stabilized by a bulge in the center and an intramo-
which is most favored by histidine. lecular hydrogen bond between the invariant P7 anchor
At the C terminus of the peptide, the conserved hy- and the peptide backbone. From the pooled sequencing
drophobic F pocket is composed of all hydrophobic side results and the sequencing of individual peptides, the
chains, including Trp147, Tyr123, Leu95, Phe116, and amino acid side-chain preferences shown at P3 and P5
Ala81. Compared with residues of H-2Kb, almost all the reflect those that would stabilize the small “hydrophobic
residues have similar side-chain conformations. The core.” Structurally, this feature could be achieved by a
only difference is the Val81Ala mutation. In Kb the Val81 broad selection of amino acids and does not impose a
side chain is intimately contacting the P9 hydrophobic rigid structural constraint on the composition of these
side chain. In Q9, the alanine at this position makes the positions as is required, for instance, at P7, where the
F pocket more spacious, with the additional volume His makes an H bond with the main chain. The predomi-
leading to a loose P9 interaction, as evidenced by the nant anchor on the P7 position gives a stringent selec-
very high temperature factor of the P9 side chain. tion of peptides at this position, through the requirement
of both the H bond with Q9 and the intramolecular H bond.
The P9 hydrophobic anchor is popular in almost allThe Q9 Peptide Binding Cleft Is Very Shallow
MHC-I, but the F pocket is not fully used in Q9. In total,and Hydrophobic
only one hydrogen bond was formed with the nonanchorThe Q9 peptide binding cleft is extremely shallow and
side-chain atoms, and the van der Waals interactionshydrophobic, compared to other class Ia and Ib mem-
between the peptide side chains and the pockets arebers that, in general, have narrow and deep grooves
not extensive.with the capacity to form polar interactions with peptide
side chains (Figure 4). The L19 peptide has 40.1% sol-
vent-accessible surface exposed, which is approxi- Stability of Q9 Complexes
The poor shape complementarity between L19 peptidemately 5%–10% greater than other classical MHC-I such
as H-2Kb-VSV8 and H-2Db-k3g. Q9 and H-2Db share and the Q9 groove, as well as the small contact interface
between the 3 domain and 2M, raised a question ofstructural features, such as a hydrophobic ridge that
separates the F pocket from the preceding region of the stability of the Q9 ternary complexes under physio-
logical conditions. To address this issue, we tested thethe groove (Figure 4b). However, in H-2Db the ridge is
composed of bulky residues Tyr73, Trp147, and Tyr156, importance of L19 residues in Q9 stabilization in a man-
ner similar to that of previous experiments analyzing Q9whereas in Q9 this ridge is less prominent because of
the use of smaller residues, yet the floor of the groove stability [29]. Class I heavy chain and 2M-containing
lysates were prepared from TAP (transporter-associatedis elevated, resulting in an overall shallower cleft. In Q9,
at the peptide N-terminal region of the groove below with processing)-deficient RMA-S cells and the forma-
tion of “conformed” Q9 and was measured by an anti-the P3-P4 backbone, a large ridge composed of Tyr99,
Trp97, Tyr159, and His70 forces the peptide backbone body-dependent assay in the presence and absence
of binding (stabilizing) and nonbinding (nonstabilizing)upwards (Figures 3a and 4a). The Tyr99-hydroxyl forms
a hydrogen bond with the P3 backbone amide nitrogen, peptides [29]. The stability of Q9-peptide complexes
mirrored the requirement for primary anchor and pre-and His70-imino nitrogen hydrogen bonds with the P3
carbonyl group and thus fixes the peptide main-chain ferred secondary residues as shown with alanine-substi-
tuted peptides (Figure 5). These results indicate thatconformation. At the C-terminal region, the ridge is
mainly due to Trp147, which forces the P8 position up- peptide binding is required for the maintenance of Q9.
Hence, despite the poor structural complementarity ofward (Figure 3a). Many side chain substitutions in the
pockets of Q9 reduce the volume of normally deep pock- the Q9-peptide interactions, the peptide is integral to
the stability of Q9.ets and contribute to the shallowness of the groove. For
Crystal Structure of a Nonclassical MHC-Peptide Complex
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Figure 6. Inefficient Binding of Q9 to CD8 is Likely Due to an Altered
AB LoopFigure 5. Q9 Stability is Peptide-Dependent and Requires Both In-
teracting and Noninteracting Peptide Residues The AB loop of Q9 is overlapped with the AB loop of H-2Kb from
the structure of the H-2Kb/CD8 complex [40]. The H-2Kb/CD8The Q9/2m complexes, released from TAP-negative RMA-S cell
complex is green, and Q9 is purple. Charged residues at the tip oflysates, were incubated with binding and nonbinding peptides and
the AB loop in H-2Kb interact with a CD8 loop. In Q9, this looptested for conformational integrity (stability) by sandwich ELISA as
is lacking these charged residues, and the body of the loop is foldeddescribed in [29]. The Q9 binding peptides were L19 and its Ala
away from the direction of CD8.substitution variants L19 1A, L19 2A, L19 4A, L19 5A, L19 6A, and
L19 8A. The nonbinding Q9 control peptides were L19 3A, L19 7A,
L19 9A (carrying Ala substitutions at anchoring positions 3, 7, and
9 [29]), VSV WT, and POLY A. The detection of high ELISA signals in crystal packing. Hence, the AB loop in Q9 appears
(expressed in arbitrary, Q9, or Kb-specific units) indicates a “con- to be limited in its ability to fold back to make contact
formed” heavy chain/2m complex.
with CD8.
Biological ImplicationsLow Efficiency of CD8 Binding by Q9
Q9 is known to have a reduced capacity to positively/
negatively select CD8 thymic T cells [37, 38] and was Q9 stands out as a hybrid with mixed features of classi-
cal and nonclassical MHC-I molecules. It has two hall-reported previously to be impaired in binding hCD8
[25]. Previous structural studies of CD8-MHC I com- marks of nonclassical MHC I, namely, extremely low
polymorphysism and low expression levels [41]. How-plexes revealed that the CD loop of the 3 domain of
the heavy chain plays a major role in interacting with ever, it exhibits the peptide binding pattern resembling
the classical, but not the nonclassical, class I. The loneCD8 [39, 40]. Compared with other murine MHC I, the CD
loop of Q9 is very similar, but the AB loop is significantly exception is the nonclassical HLA-G, which also binds
a wide array of peptides and utilizes a similar numberdifferent; the AB loop in Q9 points away from where
CD8 would normally bind class Ia (Figure 6). This loop of anchors for peptide binding [42]. Recent research
into the function of the Qa-2 molecule led to the demon-would require an almost 12 A˚ conformational change to
assume the position seen in the class Ia MHC that bind stration that it regulates NK activity [25] and CD8/
CD8 iEL (intestinal epithelial lymphocyte) T cell popu-CD8 (Figure 6). In the H-2Kb-mCD8 complex, the AB
loop contains long chain hydrophilic residues, which is lations [24] that it defines the rate of development of
early embryos [26]. The identification of Q9 as the genea feature of all murine MHC I except for Qa-2. There are
two hydrogen bonds between the H-2Kb AB loop and a controlling the preimplantation embryo development
implicates Qa-2 protein in this process, where it mayCD8 CDR-like loop [40]. H-2Kb residue 196 is a glutamic
acid, which hydrogen bonds to the ND2 of the CD8 have another specialized receptor. The multiple func-
tions of Qa-2 are likely mediated by diverse receptorsAsn61, and H-2Kb Lys198 uses the NZ atom to hydrogen
bond to CD8 Ser59. In Q9, the AB loop is lacking analo- on appropriate effectors that respond to the special
binding characteristics determined by its three-dimen-gous long-chain hydrophilic residues (Figure 6). The
Lys196 residue is substituted with tyrosine and is sur- sional structure. Similar to other MHC, Q9 exhibits nu-
merous possible interaction surfaces with receptors. Itrounded by the small residues Ser195, Gly197, and
Ala198, which make this loop a less favorable target for has now been shown that practically the entire surface
of MHC molecules is utilized for complexation with TCR,CD8 interaction. Although this loop is flexible in most
MHC I molecules, it does not appear to be flexible in NK, coreceptors, viral receptors, and others. There is
nothing about the structure of Q9 that would precludeQ9 in that it has a rigid conformation and is not involved
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dimensions a  53.92 A˚, b  56.18 A˚, and c  119.92A˚, and containany of these interactions, with the possible exception
one molecule in the asymmetric unit. X-ray diffraction data wereof CD8, as we discussed. The structural epitopes recog-
collected at beamline 9-2 (wavelength  1.08 A˚) at the Stanfordnized by TCR and NK receptors are open for ligation on
Synchrotron Radiation Laboratory (Stanford, CA) with a 30 cm diam-
Q9. Hence, speculation that Q9 could be both an  eter MAR-Research detector. The crystal diffracted to 2.3 A˚ resolu-
TCR ligand and an NK receptor are not ruled out by this tion. A total of 100 oscillation images were collected under cryo-
genic conditions (T  100 K). The data were indexed, integrated,structure.
and scaled with MOSFLM and SCALA [44]. Data collection statisticsThe biological events through which Qa-2 carries out
are presented in Table 2.its function are still being elucidated. Despite the fact
that the physiologically relevant receptor(s) of Qa-2 are
Structure Determination and Refinement
not yet defined, it is anticipated that Q9 interacts with The structure of the Q9 complex was determined by molecular re-
 TCR on CTL and with inhibitory NK receptors on LAK placement with the AMoRe program [45]. The H2-Kb-OVA crystal
cells. In humans, trophoblast-expressed HLA-G and ubiq- structure [46] with the peptide omitted was used as a search model.
2Fo  Fc and Fo  Fc maps were calculated with all the data anduitously expressed HLA-C are most reminiscent of Q9. All
the model phases. These calculations showed clear continuous den-three have limited polymorphism and bind larger reper-
sity for a peptide in the binding groove. The model was rebuilt withtoires of peptides than other known nonclassical MHC.
the amino acid sequence of Q9 with the program O [47]. It was
All three appear to be more important in NK regulation then subjected to simulated annealing with the CNS torsion angle
than in classical T cell responses, despite their ability dynamics protocol [48]. Throughout refinement, all reflection data
to bind microbially derived peptides. HLA-G and Q9 were used without sigma cutoff. Extensive use of SIGMAA-weighted
2Fo  Fc and Fo  Fc omit maps was made to reduce the model biasundergo alternative splicing, giving rise to multiple pro-
[49]. The peptide was placed with a poly-alanine chain and rebuilttein products [43]. Both subsets of isoforms include
gradually according to the emerging electron density. Water mole-membrane bound antigens as well as soluble polypep-
cules were automatically included with CNS and manually edited
tides, which circulate in blood and accumulate in immu- with electron density maps. Repeated iterations between manual
nologically privileged sites. Both HLA-G and Q9 play a rebuilding and minimization as well as B factor refinement finally
role in fetal development via NK-suspected mechanisms. resulted in a model with a converged R factor of 22.3% and an Rfree
of 27.8% [50]. The stereochemistry of the model was analyzed withThese similarities suggest that HLA-G and Q9 molecules
PROCHECK [51]. A summary of the refinement statistics is given inmay represent functional homologs, by analogy to mu-
Table 1.rine Qa-1 and human HLA-E, the two structurally diver-
gent MHC that bind very similar ligands and receptors
Graphics
in their respective hosts [12]. Future structural studies Figures of protein models were produced with Molscript [52], Ras-
of HLA-G and MHC interacting with relevant receptors ter3d [53], and Grasp [54].
may help to support or discount these speculations.
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